Menu
Back to Journals » Vascular Health and Risk Management » Volume 5
Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy
Authors Patel J, Tracey I, Hughes EA, Lip GY
Published 21 September 2009 Volume 2009:5 Pages 801—810
DOI https://doi.org/10.2147/VHRM.S4307
Review by Single anonymous peer review
Peer reviewer comments 2
Jeetesh V Patel, Inessa Tracey, Elizabeth A Hughes, Gregory YH Lip
Haemostasis, Thrombosis and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, England, UK
Abstract: Long-chain omega-3 polyunsaturated fatty acid (PUFA) supplementation has been used for the secondary prevention of fatal and nonfatal myocardial infarction (MI). However, the benefit of this therapy is frequently confused with other established treatments in the therapeutic strategy among such patients. We review the data on omega-3 PUFA use in secondary care and consider indications for its use which include post-MI and raised triglycerides. We suggest that the available evidence supports the use of omega-3 supplementation as part of the comprehensive secondary care package for post-MI patients.
Keywords: omega-3 polyunsaturated fatty acids, myocardial infarction
© 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.